Congrats to the person who created the fake Eli Lilly Twitter account and igniting a PR shaming cycle so intense that they had to cave
https://www.nytimes.com/2023/03/01/business/insulin-price-cap-eli-lilly.html
Eli Lilly to Cut Insulin Price and Cap Monthly Out of Pocket Costs at $35

The company also trumpeted an existing policy that caps monthly out-of-pocket cost for its lifesaving products at $35.

The New York Times
With that being said, Eli Lilly is still wildly overcharging U.S. patients who need insulin in comparison to other countries.
@ErickFernandez Gouge, the word is gouge.

@ErickFernandez “the policies announced Wednesday will not have much, if any, effect on what many people are actually paying.”…”Lilly plans to reduce that to $66. However, insurers already pay much less than that”

That article makes it sound like the changes they’re making are purely performative, and don’t really change anything.

@ErickFernandez hey, a positive effect of Musk owning Twitter
@ErickFernandez deleted my previous post as NYTimes has since updated the article with more details

@ErickFernandez IMO, they’ll no doubt price gouge on another drug.

I hope not, but I can see it.

@ErickFernandez @aetus something good actually came out of the blue check fiasco
@ErickFernandez can you provide more info or a way to get to that fake account? Thanks either way.

@ErickFernandez well, not really.

Like #Shkreli they only shifted from direct to indirect payment.

At this point I'm woundering why Mexican cartels haven't started mass-smuggling insulin from Mexico into the USA.

@[email protected] It is nice to think that corporations can know shame, but I am sure that if we dig deeper, we will find out that it is regulatory pressures (plus a bit of consumer pressure )